Scholarlink

<p>Nature’s structural and functional complexity is inspired by Biomimetic materials, which transform regenerative medicine and tissue engineering by offering advanced solutions for diabetes management and wound healing. The traditional material is combined with a hierarchical design based on natural tissues and advanced fabrication technologies like 3D printing, electrospinning, and prototyping, which allows the multifunctional scaffolds to replicate the extracellular matrix (ECM). The collagen–polymeric carbohydrate hybrids, when crosslinked with graphene-based fillers, improve cellular adhesion and proliferation, as implemented by the current advancement for providing the 3D support. The viability of the fibroblast is improved by 90% by using the electrospun nanofiber scaffolds fabricated with polymeric carbohydrates, and also improves the collagen deposition, which leads to quicker wound healing. The higher biomineralization is attained by the collagen–chitosan composites compared to collagen-alginate scaffolds, also 25% of mechanical stability is also increased, which makes the model suitable for bone regeneration. Additionally, in diabetes therapy, remarkable results have been attained by the biomimetic nanofiber scaffolds seeded with pancreatic β-cells. The maintenance of sustained insulin secretion and normoglycemia for one year when β-cell seeded silk fibroin scaffolds were implanted at epididymal fat pads, this approach surpasses the islet transplantation according to the animal study report. Additionally, the diabetic patients are able to achieve long-term normoglycemia with insulin independence for 12&#xa0;months by fibrin-based scaffolds that are transplanted within the omentum region. The natural gum-based scaffolds, like carboxymethyl guar-gum (CMGG) hydrogels and electrospun nanofibers, can provide moisture retention, good swelling capacity, and fibroblast proliferation for wound healing. The healing time and burn wound are reduced by around 95% by the CMGG scaffolds that enhance the macrophage-mediated tissue compared to traditional dressing. In rabbit wound models, the epithelialization is increased by the polycaprolactone nanofibers and Electrospun spider silk, which attain 25% quicker than standard controls, and the wound closure occurs within 21&#xa0;days. In addition, the further enhancement of the application of biomimetic scaffolds in bone repair is achieved by combining bioceramics like hydroxyapatite with polymeric matrices. The hybrid composites not only enhance the osteoconductivity and bioactivity, but also enhance the implementation of the sustained mechanical integrity in load-bearing cases. Moreover, the advancement in the decellularized ECM scaffolds and thermo-responsive cell sheet technologies has expanded the regenerative neural, vascular and dermal applications. The ability of the nature-inspired materials in replicating biological functionality is highlighted by the innovation approach, and also traditional limitations are overcome by the innovation approach. The high biodegradability, biocompatibility, and multifunctionality are attained by the biomimetic scaffolds using the convergence of natural design principles with modern fabrication techniques. The scaffolds improve the wound closure and also bone regeneration by allowing long-term Glycemic control in diabetic models. The future development is optimizing scaffold vascularization, measuring the clinical applications, and combining the smart biomaterials with bioactive molecules to further improve the regenerative results. This growing evidence supports biomimetic materials as a revolutionary platform for the upcoming generations in therapies for diabetes management, tissue engineering, and wound healing.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nature-inspired biomimetic scaffold materials for tissue engineering and regenerative medicine: treating diabetes and wound healing

  • 期刊论文

  • 发表日期：

    2025年11月17日

查看全文
  • Shubham Sharma,
  • Krishnaraj Ramaswamy

摘要

Nature’s structural and functional complexity is inspired by Biomimetic materials, which transform regenerative medicine and tissue engineering by offering advanced solutions for diabetes management and wound healing. The traditional material is combined with a hierarchical design based on natural tissues and advanced fabrication technologies like 3D printing, electrospinning, and prototyping, which allows the multifunctional scaffolds to replicate the extracellular matrix (ECM). The collagen–polymeric carbohydrate hybrids, when crosslinked with graphene-based fillers, improve cellular adhesion and proliferation, as implemented by the current advancement for providing the 3D support. The viability of the fibroblast is improved by 90% by using the electrospun nanofiber scaffolds fabricated with polymeric carbohydrates, and also improves the collagen deposition, which leads to quicker wound healing. The higher biomineralization is attained by the collagen–chitosan composites compared to collagen-alginate scaffolds, also 25% of mechanical stability is also increased, which makes the model suitable for bone regeneration. Additionally, in diabetes therapy, remarkable results have been attained by the biomimetic nanofiber scaffolds seeded with pancreatic β-cells. The maintenance of sustained insulin secretion and normoglycemia for one year when β-cell seeded silk fibroin scaffolds were implanted at epididymal fat pads, this approach surpasses the islet transplantation according to the animal study report. Additionally, the diabetic patients are able to achieve long-term normoglycemia with insulin independence for 12 months by fibrin-based scaffolds that are transplanted within the omentum region. The natural gum-based scaffolds, like carboxymethyl guar-gum (CMGG) hydrogels and electrospun nanofibers, can provide moisture retention, good swelling capacity, and fibroblast proliferation for wound healing. The healing time and burn wound are reduced by around 95% by the CMGG scaffolds that enhance the macrophage-mediated tissue compared to traditional dressing. In rabbit wound models, the epithelialization is increased by the polycaprolactone nanofibers and Electrospun spider silk, which attain 25% quicker than standard controls, and the wound closure occurs within 21 days. In addition, the further enhancement of the application of biomimetic scaffolds in bone repair is achieved by combining bioceramics like hydroxyapatite with polymeric matrices. The hybrid composites not only enhance the osteoconductivity and bioactivity, but also enhance the implementation of the sustained mechanical integrity in load-bearing cases. Moreover, the advancement in the decellularized ECM scaffolds and thermo-responsive cell sheet technologies has expanded the regenerative neural, vascular and dermal applications. The ability of the nature-inspired materials in replicating biological functionality is highlighted by the innovation approach, and also traditional limitations are overcome by the innovation approach. The high biodegradability, biocompatibility, and multifunctionality are attained by the biomimetic scaffolds using the convergence of natural design principles with modern fabrication techniques. The scaffolds improve the wound closure and also bone regeneration by allowing long-term Glycemic control in diabetic models. The future development is optimizing scaffold vascularization, measuring the clinical applications, and combining the smart biomaterials with bioactive molecules to further improve the regenerative results. This growing evidence supports biomimetic materials as a revolutionary platform for the upcoming generations in therapies for diabetes management, tissue engineering, and wound healing.